Introduction {#sec1_1}
============

Subarachnoid hemorrhage (SAH) is a challenging cerebrovascular disease with complex mechanisms threatening brain perfusion and function. The therapeutic challenge is to actively treat and optimize cerebral hemodynamics at bedside, prevent secondary insult and improve clinical outcome. After SAH, a context of cerebral energy crisis has been demonstrated \[[@B1]\]. This crisis might be magnified by secondary insults, such as vasospasm and hydrocephalus that contribute to unfavorable outcome via biochemical and biomechanical aggressions. The biochemical stress is related to the presence of blood-derived compounds that alter microvascular function, yielding vascular spasm with reduction of blood delivery that intensifies the oligemic brain vulnerability \[[@B2]\]. The biomechanical stress is mainly related to raised intracranial pressure (ICP) \[[@B3]\] that reduces the cerebral perfusion and threatens the brain function \[[@B4]\].

Patients with good-grade SAH (WFNS 1 or 2) \[[@B5]\] are those without initial neurological deficit. However, they can die or present severe deficit due to delayed insult leading to brain ischemia \[[@B6]\]. This fragile population mandates an optimal treatment, but little is known with respect to ICP management.

In clinical practice, lumbar puncture (LP) is sometimes performed to withdraw CSF and to release headaches in awake patients after SAH. The indication of LP is mainly based on an empirical and controversial approach. There is no clear evidence of the benefit of this procedure neither in terms of headache, drop-in ICP nor in change in cerebral hemodynamics.

We hypothesize that in good-grade SAH patients, a 20-ml LP reduces -- within a time frame of one hour -- headache and ICP, but also improves cerebral hemodynamics as measured with O^15^ positron emission tomography (PET).

Methods {#sec1_2}
=======

Patients {#sec2_1}
--------

Patients with good-grade SAH (WFNS 1 or 2) \[[@B5]\] were eligible to this study. They all presented an acute headache, were conscious and had no focal neurological deficit. The diagnosis of SAH was confirmed by the presence of blood in the subarachnoid spaces on CT scan, graded with the Fisher score. The degree of ventricular dilatation was measured with the frontal ventricle/cerebral index or Evan\'s index (normal \<30%). Patients were transferred to our Stroke Unit. No LP had been performed at that time. The origin of the bleed was investigated with angiography under general anesthesia within the first 24 hours. An aneurysm was detected in every patient, and successfully treated with endovascular coiling. No actual vasospasm was identified. Patients were managed according to our local protocol associating painkillers (stepwise from paracetamol 1 g i.v. every 8 h to morphine sulfate 2--4 mg i.v. every 2--4 h), nimodipin (60 mg p.o. every 4 h for 21 days), enoxaparin (0.4 ml/day s.c.), pravastatin (40 mg/day p.o.). We perform LP for severe headaches when the visual analog scale (VAS) \>7 despite maximal painkiller treatment (paracetamol and morphine).

Inclusion criteria were as follows: (i) WFNS 1 or 2 SAH with treated aneurysm and (ii) severe headache requiring an LP in our institution to withdraw 20 ml CSF, (iii) signed consent and (iv) no anticoagulants 12 h prior to the LP.

Patient Inclusion {#sec2_2}
-----------------

At our institution, we perform LP in about 30 % of our good-grade SAH patients. Within the 18-month inclusion period, 40 patients were admitted for good-grade SAH in our Stroke Unit. The study was proposed to all patients who required an LP. Nine patients agreed to participate to the study. Two patients were finally not included because of cyclotron problem. Seven patients were actually included with signed consent, but one patient moved during the second PET run and the cerebral blood flow (CBF) analysis was not interpretable. Despite our endeavor, we finally included and analyzed 6 patients in this prospective study.

Study Procedure {#sec2_3}
---------------

The study procedure was performed between day 2 and day 5 after the SAH onset (table [1](#T1){ref-type="table"}). It sequentially consisted of (i) a pre-LP pain estimation with VAS, (ii) an ICP and noninvasive arterial blood pressure (ABP) monitoring, (iii) a PET measurement of CBF (3 consecutive runs), (iv) a 20-ml CSF removal, (v) a second PET measurement of CBF (3 consecutive runs) and finally (vi) a post-LP pain evaluation with VAS. The whole procedure lasted 2 hours and was performed in the PET Scan area.

ICP and ABP Monitoring Technique {#sec2_4}
--------------------------------

The patient was lying horizontally in the left lateral position. After local anesthesia a 20G lumbar needle was inserted in the L4--L5 interspinous space and was left in place during the whole procedure. The lumbar puncture allows gauging ICP in communicating hydrocephalus \[[@B7]\] and SAH \[[@B8]\]. Therefore CSF lumbar pressure was used in this protocol as a surrogate measurement of ICP. The CSF pressure was measured with a fluid transducer. The zero reference pressure was the atmospheric pressure at the level of the foramen of Monro. ABP was monitored noninvasively using photoplethysmography with a cuff placed on the left medius. The pressure monitors were connected to an analog-to-digital converter, fitted into a computer running a dedicated software (<http://www.neurosurg.cam.ac.uk/icmplus>, Cambridge University, UK) \[[@B9]\].

The waveforms of ICP and ABP were sampled and digitized. The digital signals were analyzed off-line. ICP mean (ICPm), ABP mean (ABPm) and cerebral perfusion pressure (CPP = ABPm -- ICPm) were calculated. ICP pulse amplitude (ICPa) was processed as the first harmonic component of ICP. Pressure-volume compensatory reserve was estimated by the RAP index \[[@B10]\], calculated as the linear correlation coefficient between ICPm and ICPa. When the pressure-volume compensatory reserve is preserved, small intracranial volume does not influence the pulsatility of ICP producing a lack of coupling between changes in ICPm and in ICPa, demonstrated by a correlation coefficient close to 0. RAP index close to 0 indicates a preserved pressure-volume compensatory reserve. Conversely when the pressure-volume compensatory reserve is altered, ICPm and ICPa are positively coupled with a RAP index close to +1.

PET Technique {#sec2_5}
-------------

The scanner used was an EXACT HR+ (CTI/Siemens CTI, Knoxville, Tenn., USA). The whole brain was imaged. For attenuation correction, a 10-minute transmission scan was acquired with a 68Ge/68Ga ring source. After reconstruction, axial and in-plane resolution was 4.1--4.5 mm. During the whole procedure, subjects were kept in left lateral position in a vacuum mattress. The light was dimmed in a quiet camera room, the patients were asked to lie calm with their eyes closed during the whole procedure, avoiding any head movement. CBF was monitored with intravenous bolus injections of oxygen-15-radiolabeled water (H~2~^15^O) as a blood flow tracer. To improve reliability of the measurement, each subject received 3 consecutive intravenous boluses of 300 MBq of H~2~^15^O. Then 3 PET scans were acquired to measure CBF at baseline. Then 20 ml CSF were drained by simple gravity after opening a three-way tap on the LP needle. Subsequently the tap was closed and finally 3 intravenous injections of 300 MBq and 3 PET scans were performed. In order to obtain a significant reduction of the injected radioactivity (half-life of H~2~^15^O = 123 s), at least 10 minutes elapsed between each scan. PET data were reconstructed by filtered back projection with corrections for attenuation, scatter, randoms, dead time, and decay and smoothed by a Gaussian function with 7.3-mm full-width half-maximum.

Data Analysis {#sec2_6}
-------------

Data are expressed as mean ± standard deviation. The nonparametric Wilcoxon test for paired data was used for clinical and monitoring data. All calculations were performed using Statistica 6.1 (StatSoft, Inc).

Image Analysis {#sec2_7}
--------------

We semiquantitatively measured CBF and performed two different image analyses: one descriptive and one statistical analysis.

The first descriptive analysis was performed using the raw signal, normalized to mean cerebral activity and we applied a Brodmann mask \[<http://www.cabiatl.com/mricro/mricro/mricro.html>\] on the images. We measured the mean value of the pixels for each Brodmann area at baseline and after the LP. Then we calculated the difference between baseline and post-LP condition for each Brodmann area: positive value means augmentation of relative CBF after the LP, negative value means reduction of regional CBF (rCBF). The semiquantitative results were displayed graphically with axial views of the brain.

The second analysis was performed using Statistical Parametric Map (SPM 5) (Wellcome Department of Cognitive Neurology, Institute of Neurology, London, UK). We analyzed the variation in rCBF. rCBF data were covaried for all voxels and comparisons across the two conditions (before and after CSF drainage) were made using t statistics with appropriate linear contrasts and then converted to Z scores. Only regions that exceeded a threshold of p \< 0.05 (Z score \>3.2) were considered significant. This analysis allows showing significant increase or decrease of blood flow after the LP.

Protocol Approvals and Patient Consents {#sec2_8}
---------------------------------------

Our local research ethics committee approved the study and a signed consent was obtained from all patients participating in the study.

Results {#sec1_3}
=======

Pain {#sec2_9}
----

One hour after LP, pain decreased in all patients with a significant mean drop of −4 (table [1](#T1){ref-type="table"}).

Monitoring Analysis {#sec2_10}
-------------------

An example of the recording is displayed figure [1](#F1){ref-type="fig"}, and results are given in table [2](#T2){ref-type="table"}. The mean baseline ICP was 24.3 ± 12.5 mm Hg with high pulsatility pattern, demonstrating at baseline an intracranial hypertension in our group of patients. The withdrawal of 20 ml of CSF produced a rapid drop in ICP down to a mean value of 6.9 ± 4.7 mm Hg (p = 0.02). ICP pulse amplitude plunged from 5.76 ± 5.14 to 0.86 ± 0.37 mm Hg. RAP significantly dropped from 0.77 ± 0.14 to 0.22 ± 0.15 (p = 0.02) suggesting that pressure-volume compensatory reserve improved after LP. There was no change in mean ABP (97.4 ± 11.1 vs. 101.6 ± 9.1 mm Hg). CPP increased significantly from 73.1 ± 8.4 to 94.7 ± 8.5 mm Hg (p = 0.02) as a direct consequence of the drop in ICP.

Cerebral Hemodynamic Analysis {#sec2_11}
-----------------------------

### Descriptive Individual Analysis {#sec3_1}

We first performed descriptive semiquantitative regional CBF analysis: for each patient we imaged the increase and decrease in blood flow after LP (fig. [2](#F2){ref-type="fig"}).

Patient 1 (anterior communicating artery, AcomA): increase in rCBF in the bifrontal and left temporal regions; reduction in the posterior and right parieto-occipital area.

Patient 2 (AcomA): global reduction in rCBF; increase in blood flow in very limited regions.

Patient 3 (right middle cerebral artery, rMCA): rCBF augmented prominently on the right hemisphere; parallel diminution on the left.

Patient 4 (rMCA): increase on the right hemisphere and posteriorly; rCBF was reduced on the left.

Patient 5 (AcomA): increase bifrontally and in the right hemisphere; reduction on the left temporal.

Patient 6 (AcomA): augmentation in the bifrontal and reduction in the posterior regions.

Overall, LP seems to yield a heterogeneous and biphasic effect: rCBF increases in one area of the brain, and a rather symmetrical decrease took place on the opposite side. This biphasic effect has roughly a bilateral symmetry, with a coronal plane symmetry in AcomA aneurysm patients, and sagittal plane symmetry in patients with rMCA aneurysm.

### Statistical Group Analysis {#sec3_2}

We performed a statistical analysis of the AcomA group (n = 4) and color-coded augmentation and reduction of blood flow on a brain surface rendering (fig. [3](#F3){ref-type="fig"}). The LP produced a significant increase in rCBF mainly in the bifrontal and interhemispheric region, wider than the strict AcomA vascular territory, and a significant reduction of blood flow in the posterior part of the brain. The increase (resp. decrease) in rCBF took place in regions close to (resp. remote from) the bleed.

Conclusions {#sec1_4}
===========

This prospective study provides novel and clinically important information on the consequences of subtractive LP in good-grade SAH patients.

After SAH, outcome depends on primary brain insults, which are not preventable, but also on secondary insults like vasospasm, delayed ischemic deficit and hydrocephalus, which are potentially preventable. Patients with good-grade SAH are initially in good neurological status as they did not encounter massive primary insults, but can present subtle neurological signs which are associated with worse outcome \[[@B6]\]. These fragile patients without initial deficit can die or present severe deficit due to secondary lesions leading to brain ischemia \[[@B11]\]. LP might be a clinically useful tool to reduce ICP and ameliorate blood delivery to the brain.

To our knowledge, this is the first case series that addresses the consequences of an LP in good-grade SAH patients, in terms of pain, brain biophysics and cerebral hemodynamics. This is also the first time that cerebrovascular reactivity is imaged in vivo, in a fragile SAH population, following a drop in ICP.

Patients with SAH Are at Risk of Ischemia {#sec2_12}
-----------------------------------------

After SAH, an oligemic context has been demonstrated in both experimental and clinical investigations heralding a brain energy failure \[[@B4]\].

In our patients, brain energy production could be jeopardized due to secondary insults: rebleed, vasospasm and hydrocephalus. Rebleed was avoided by rapid coiling of the aneurysm. Vasospasm is a SAH-specific complication related to the narrowing of the vessels on the angiography. Vasospasm appears from day 2 to 15, and peaks at day 4 to 7 \[[@B12]\]. Only 30% of the patients with vasospasm actually develop neurological signs, a condition termed delayed ischemic deficit (DID) \[[@B12]\]. DID is correlated with up to 3-fold increase in mortality within the first 2 weeks after SAH \[[@B13]\]. But vasospasm does not resume vascular dysfunction after SAH \[[@B14]\]. Hydrocephalus might also produce secondary lesion after SAH, but its incidence is underevaluated. Acute ventricular dilation after SAH is reported up to 30%, most of the time associated with raised ICP and clinical worsening \[[@B15]\]. Acute hydrocephalus with raised ICP might impede the blood delivery. Indeed ICP and vascular wall tension represent constricting forces acting on the vessel; on the contrary, ABP is a dilating force \[[@B16],[@B17]\]. Hence raised ICP should constrict the vessels and reduce blood delivery. Draining CSF should reduce ICP and dilate the cerebral vasculature. But thanks to autoregulation, vascular smooth muscle cells should constrict to maintain CBF constant \[[@B18]\]. If autoregulation is efficient, a reduction of ICP should not influence blood delivery.

CSF Withdrawal and Brain Biomechanics {#sec2_13}
-------------------------------------

Our data demonstrates a biomechanical hazard to the brain with raised ICP and deranged pressure-volume compensatory reserve, i.e. unability of the craniospinal space to tolerate volume changes. As expected, LP seems to have a significant effect to reduce ICP but also to ameliorate the craniospinal compliance, at least temporarily. In good-grade SAH, a 20-ml LP seems to be an interesting tool to improve the biomechanical conditions that act onto the brain.

Changes in CBF Induced by an LP {#sec2_14}
-------------------------------

We analyzed how the blood flow is actively redistributed within the brain after a drop in ICP, in other words how reactive the brain microcirculation is to maintaining constant blood flow. Our data suggest a heterogeneous and biphasic cerebrovascular reactivity due to the sole ICP drop induced by an LP. There are various ways to address cerebrovascular reactivity: acetazolamide, CO~2~, ABP change, etc. Our study refers to a different approach: ICP drop is a pure biomechanical trigger irrespective of any indirect or systemic effect. Our results advocate for a heterogeneous and biphasic effect of LP on cerebral hemodynamics. It seems that rCBF augmented in the brain\'s region with blood in the subarachnoid space and was reduced on the opposite side of the brain. To our knowledge, this is the first time that small-vessel reactivity is imaged without any pharmacological mean after SAH. In two recent studies, heterogeneity of CBF has been demonstrated to be associated with worse clinical outcome \[[@B19],[@B20]\]. Our study does not confirm the heterogeneity of blood flow, but suggests that microcirculation reactivity is also heterogeneous and surprisingly biphasic.

A 20-ml LP seems to increase blood flow in certain regions of the brain tissue. An increase in rCBF after a drop in ICP heralds a defective autoregulation as stated above. Autoregulation and vasospasm are two intermingled phenomena: alteration of autoregulation seems to precede and be magnified by vasospasm \[[@B21]\], but also to be a predictor of DID \[[@B22]\]. Our results suggest an altered autoregulation in the SAH region. A 20-ml LP seems to produce also a reduction of the blood delivery in various regions, surprisingly in the brain tissue remote from the bleed. This hemodynamic pattern has never been described before, and relates neither to a steal phenomenon nor to autoregulation. The reduction of blood flow has to be a consequence of an active vasoconstriction of the local microcirculation, overtaking the relative vasodilation due to the drop in ICP. In normal brain, the blood flow control depends on pressure responsiveness, vasoactive agents, and on local neuronal activity. The neuronal control plays a major role in the regulation of vascular tone and brain perfusion. It is a key determinant in the spatial and temporal adaptation of local blood distribution \[[@B23]\]. After SAH, the sympathetic system is overactive and brain vessel sensitivity to catecholamine is also increased \[[@B24]\]. The unexpected drop in blood flow could be due -- at least partially -- to a derangement of the neuronal vascular control.

LP in the Armamentarium of SAH {#sec2_15}
------------------------------

In good-grade SAH, the current therapeutic strategies to avoid stroke is to prevent insults of systemic origin, administer painkiller, nimodipin, statin and to address large-artery vasospasm with angiography.

We demonstrated that within a one-hour time frame, LP improves headaches, reduces ICP, ameliorates the pressure-volume compensatory reserve and has a significant effect on cerebral blood flow. In this study, we cannot state whether LP prevents the constitution of vasospasm or DID, or improves blood flow. However, the clinical benefit of CSF withdrawal has been suggested in other retrospective studies: CSF lumbar drainage protocol seems to reduce the risk of DID and to improve outcome \[[@B25],[@B26]\]. Lumbar drain could remedy intracranial hypertension, improve brain biomechanics and potentially ameliorate blood delivery to the brain. CSF withdrawal might also be useful to remove biochemical compounds that might contribute to microvessel dysfunction favoring vasospasm, like bilirubin oxidation products (BOXes) \[[@B2]\].

Limits of the Study {#sec1_5}
===================

Our study has two major limits: the low recruitment and the poor temporal analysis. The low recruitment is the burden of acute PET studies and has been addressed in details in the Methods chapter. PET scanner has an excellent spatial but a poor temporal resolution. The study was designed to analyze the one-hour time frame effects of an LP in good-grade SAH patients. The mid- and long-term effects of an LP needs further work in a larger group.

Funding {#sec1_6}
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![Example of a recording (patient 4). Intracranial pressure mean (ICPm) and ICP pulse amplitude (ICPa) are measured with a lumbar needle. ICP is elevated (mean 33 mm Hg) demonstrating an intracranial hypertension at baseline. Arterial blood pressure mean (ABPm) is measured noninvasively. At 10 min, 20 ml of CSF are drained via a 3-way tap; ICPm and ICPa drop immediately. At 14 min, the 3-way tap is closed. ICPm and ICPa are below the baseline value. ABP is stable.](cee-0002-0052-g01){#F1}

![Axial view of individual rCBF changes. For each patient, we imaged semiquantitatively the changes in regional CBF after a 20-ml LP. Red means increase in blood flow after the LP, whereas green means decrease in rCBF. Note the heterogeneity of the cerebrovascular reactivity after an LP, and the biphasic effect with increase in blood flow on one side and decrease on the other side.](cee-0002-0052-g02){#F2}

![Statistically significant change in rCBF on a brain surface rendering. AcomA subgroup (n = 4, Z score \>3.2). Changes in regional blood flow following a 20-ml LP, color-coded on a brain surface rendering. An increase in blood flow, represented in red, was prominent in the anterior interhemispheric region, but also in the bifrontal area with blood in the subarachnoid space. A decrease in blood flow, in green, was identified in the brain tissue remote from the bleed, especially in the posterior part of the brain.](cee-0002-0052-g03){#F3}

###### 

Demographics and clinical data

  Patient   Sex     Age   Admission WFNS   Fisher score   Evan\'s index   Aneurysm location   Day of coiling after SAH   Day of PET after SAH   Change in VAS   GOS
  --------- ------- ----- ---------------- -------------- --------------- ------------------- -------------------------- ---------------------- --------------- -----
  1         m       46    1                4              0.29            AcomA               1                          4                      −4              5
  2         f       43    1                2              0.22            AcomA               1                          5                      −5              4
  3         m       52    1                2              0.22            rMCA                1                          4                      −1              5
  4         f       39    2                4              0.22            rMCA                1                          2                      −2              5
  5         m       57    1                3              0.26            AcomA               1                          3                      −5              4
  6         m       55    1                3              0.28            AcomA               1                          3                      −5              4
                                                                                                                                                                
            4m/2f   48    1                3              0.24            4 AcomA 2 rMCA      1                          3.5                    −4              

Total and mean values are indicated in the last line.

###### 

Monitoring data

  Patient     Baseline      After LP                                                                                                     
  ----------- ------------- ------------- ------------- ------------- ------------ ----------- ------------- ------------- ------------- ------------
  1           29.5          6.1           0.97          104           74.5         7.47        0.71          0.2           109           101.5
  2           13.9          0.742         0.56          94            80.1         7.45        0.91          0.34          95            87.6
  3           11.9          1.27          0.74          95.6          83.7         6.27        1.26          0             109           102.7
  4           33.1          6.53          0.91          93.9          60.8         13.7        0.92          0.25          98.3          84.6
  5           15.1          4.92          0.68          82            66.9         −1.1        0.22          0.21          88.2          89.2
  6           42.5          15            0.78          115           72.5         7.27        1.15          0.38          110           102.7
                                                                                                                                         
  Mean ± SD   24.3 ± 12.5   5.76 ± 5.14   0.77 ± 0.14   97.4 ± 11.1   73.1 ± 8.4   6.9 ± 4.7   0.86 ± 0.37   0.22 ± 0.15   101.6 ± 9.1   94.7 ± 8.5

Mean and SD of various monitoring indices before and after the LP for each patient: mean and pulse amplitude of intracranial pressure (ICPm and ICPa, respectively), pressure-volume compensatory reserve (RAP), arterial blood pressure mean (ABPm) and cerebral perfusion mean (CPPm).
